1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Prevalence and size of pelvic sentinel lymph node metastases in endometrial cancer
(
- Contribution to journal › Article
- 2023
-
Mark
Tru-Cut Biopsy in Gynecological Cancer: Adequacy, Accuracy, Safety and Clinical Applicability
(
- Contribution to journal › Article
- 2022
-
Mark
Copy number signatures for early diagnosis of high-grade serous ovarian carcinoma
2022) “FUTURE PERSPECTIVES IN OVARIAN CANCER RESEARCH”(
- Contribution to conference › Poster
-
Mark
Ovarian tumor frozen section, a multidisciplinary affair
(
- Contribution to journal › Article
- 2021
-
Mark
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
(
- Contribution to journal › Article
- 2020
-
Mark
PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
(
- Contribution to journal › Article
-
Mark
SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery
(
- Contribution to journal › Article
- 2019
-
Mark
Detecting TP53 mutations in diagnostic and archival liquid-based Pap samples from ovarian cancer patients using an ultra-sensitive ddPCR method
(
- Contribution to journal › Article
- 2017
-
Mark
Description of a reproducible anatomically based surgical algorithm for detection of pelvic sentinel lymph nodes in endometrial cancer
(
- Contribution to journal › Article
- 2014
-
Mark
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
(
- Contribution to journal › Article